Small Cell Lung Cancer Extensive Stage
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer Extensive Stage.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer [Phase 2]
This entry provides an update on a Phase 2 trial evaluating talazoparib in combination with low-dose temozolomide for relapsed or refractory…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)
This document covers a planned retrospective real-world study assessing the efficacy and safety of using Anlotinib hydrochloride in combinat…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy [Phase 2]
A Phase 2 clinical trial evaluating sintilimab plus anlotinib as second- or later-line therapy for extensive-stage small cell lung cancer th…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease [Phase 2]
A Phase 2 study evaluating thoracic radiotherapy with atezolizumab for extensive-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC [Phase 2]
Phase 2 trial update for Cadonilimab (AK104) with or without chemotherapy as second-line treatment for extensive-stage small cell lung cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors [Phase 2]
A Phase 2 clinical trial update exploring thoracic radiotherapy (TRT) for extensive-stage small cell lung cancer after initial treatment wit…
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating nivolumab in combination with 177Lu-DOTA0-Tyr3-Octreotate for extensive-stage small cell lung cancer has complete…
-
CLINICAL_TRIALS trial_result · 2020-05-19Clinical Trial Update: Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab plus amurubicin in patients with refractory small cell lung cancer (extensive stage).